Behavioral response to emotional stress in rabbits: Role of serotonin and serotonin2A receptors

Behavioural Pharmacology

Volumn 18, Issue 7, 2007, Pages 651-659

  Aloyo, Vincent J ^a   Dave, Kuldip D ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

5,7 DHT; 5 HT 2A receptor; 5 HT1A receptor; Buspirone; Emotional stress; M 100; Novel environment; Open field; Rabbit; Serotonin

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; ANXIOLYTIC AGENT; BUSPIRONE; CROTOXIN; DESIPRAMINE; KETANSERIN; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; EMOTIONAL STRESS; ENVIRONMENT; GENE FUNCTION; GROOMING; MALE; NONHUMAN; RABBIT; SEROTONIN BLOOD LEVEL; SEROTONINERGIC SYSTEM; STATISTICAL SIGNIFICANCE;

5,7-DIHYDROXYTRYPTAMINE; ANIMALS; BEHAVIOR, ANIMAL; BUSPIRONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROBENZENES; HEAD MOVEMENTS; MALE; MOTOR ACTIVITY; PIPERIDINES; RABBITS; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN; STRESS, PSYCHOLOGICAL;

EID: 34948906256     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3282effc0d     Document Type: Article

References (45)

1. Adell A, Casanovas JM, Artigas F (1997). Comparative study in the rat of the actions of different types of stress on the release of 5-HT in øraphe nuclei and forebrain areas. Neuropharmacology 36:735-741.
2. 2C receptors in the rabbit: high correlation with the profile for the human receptors. Eur J Pharmacol 406:163-169.
3. 2A receptors in the rabbit. J Pharmacol Exp Ther 299:1066-1072.
4. Alper RH (1990). Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat. Neuroendocrinology 51:255-260.
5. Brocco M, Dekeyne A, Veiga S, Girardon S, Millan MJ (2002). Induction of locomotion in mice exposed to novel environment by inhibition of serotonin reuptake, a pharmacological characterization of diverse classes of anti-depressant drugs. Pharmacol Biochem Behav 71:667-680.
6. Brown GW (1993). Life events and affective disorders: replications and limitations. Psychosom Med 55:248-259.
7. Buckholtz NS, Zhou DF, Freedman DX, Potter WZ (1990). Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain. Neuropsychopharmacology 3:137-148.
8. 1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxylmethamptheamine. Neuropsychopharmacology 7:113-127.
9. Candland DK, Nagy ZM (1969). The open field: some comparative data. Ann NY Acad Sci 159:831-851.
10. 2C receptor activation. Pharmacol Biochem Behav 72:371-378.
11. 2A receptors in the CA1 field of the hippocampus mediate head movements in the rabbit. Psychopharmacology 176:287-295.
12. 2 receptors in mediating head bobs and body shakes in the rabbit. Pharmacol Biochem Behav 77:623-629.
13. Denenberg VH (1969). Open field behavior in the rat: what does it mean? Ann NY Acad Sci 159:852-859.
14. Deyo RA, Straube KT, Moyer JR, Disterhoft JF (1989). Nimodipine amerliorates aging-related changes in open field behaviors of the rabbit. Exp Aging Res 15:169-175.
15. Fenske M, Fuchs E, Probst B (1982). Corticosteroid, catecholamine and glucose plasma levels in rabbits after repeated exposure to a novel environment or administration of (1-24) ACTH or insulin. Life Sci 31:127-132.
16. Fibiger HC, Campbell BA (1971). The effect of para-chlorophenylalanine on spontaneous locomotor activity in the rat. Neuropharmacology 10:25-32.
17. Fontani G, Farabollini F, Carli G (1984). Hippocampal electrical activity and behavior in the presence of novel environmental stimuli in rabbits. Behav Brain Res 13:231-240.
18. Fuller RW (1990). Serotonin receptors and neuroendocrine response. Neuropsychopharmacology 3:495-502.
19. Fuller RW (1996). Serotonin receptors involved in the regulation of pituitary-adrenocortical function in rats. Behav Brain Res 73:215-219.
20. Ge J, Barnes NM, Costall B, Naylor RJ (1997). Effect of aversive stimulation on 5-hydroxytryptamine and dopamine metabolism in the rat brain. Pharmacol Biochem Behav 58:775-783.
21. Geyer MA (1996). Serotonergic functions in arousal and motor activity. Behav Brain Res 73:31-35.
22. Gispen-de Wied CC (2000). Stress in schizophrenia: an integrative view. Eur J Pharmacol 405:375-384.
23. 2-adrenergic receptors underlie its actions. Neuroscience 93:1251-1262.
24. Graeff FG (2002). On serotonin and experimental anxiety. Psychopharmacology 163:467-476.
25. Griebel G (1995). 5-hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65:319-395.
26. Handley SL (1995). 5-hydroxytryptamine pathways in anxiety: its treatment. Pharmacol Ther 66:103-148.
27. Hollister LE (1984). Effects of hallucinogens in humans. In: Jacobs BL, editor. Hallucinogens: neurochemical, behavioral and clinical perspectives. New York: Raven Press. pp. 19-33.
28. Hoyer D, Hannon JP, Martin GR (2002). Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533-554.
29. Johnson MP, Siegel BW, Carr AA (1996). [3H]MDL 100,907: a novel selective 5-HT2A receptor ligand. Naunyn-Schmiedebergs Arch Pharmacol 354:205-209.
30. Kral K (2003). Behavioural-analytical studies of the role of head movements in depth perception in insects, birds and mammals. Behav Proc 64:1-12.
31. Lopez JF, Akil H, Watson SJ (1999). Neural circuits mediating stress. Biol Psychiatry 46:1461-1471.
32. Lucki I (1998). The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44:151-162.
33. Miura H, Qiao H, Ohta T (2002). Attenuating effects of the isolated rearing condition on increased brain serotonin and dopamine turnover elicited by novelty stress. Brain Res 926:10-17.
34. Munson PJ, Rodbard D (1980). LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
35. Nalivaiko E, Blessing WW (2003). CRF-1-Receptor antagonist CP-154526 reduces alerting-related cutaneous vasoconstriction in conscious rabbits. Neuroscience 117:129-138.
36. Nemeroff CB (1998). Psychopharmacology of affective disorders in the 21st century. Biol Psychiatry 44:517-525.
37. Noguchi T, Yoshida Y, Chiba S (2001). Effects of psychological stress on monoamine systems in subregions of the frontal cortex and nucleus accumbens of the rat. Brain Res 916:91-100.
38. Paulus MA, Geyer MA (1992). The effects of MDMA and other methylenedioxy-substituted phenalkylamines on the structure of rat locomotor activity. Neuropsychopharmacology 7:15-31.
39. Prut L, Belzung C (2003). The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3-33.
40. 1A receptors and changes in the extracellular 5-HT in the guinea-pig prefrontal cortex: involvement in aversive behavior. J Psychopharmacol 7:338-345.
41. 2A receptor in vivo. Psychopharmacology 184:173-181.
42. 1A agonists. J Pharmacol Exp Ther 247:1073-1081.
43. 2C, receptor. Psychopharmacology 144: 248-254.
44. 2A receptors stimulate ACTH, corticosterone, oxytocin, rennin and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells. J Neurosci 21:3572-3579.
45. Walsh RN, Cummins RA (1976). The open-field test: a critical review. Psychol Bull 83:482-504.